Form D · Other Investment Fund

MANHATTAN SCIENTIFICS INC

New York, NY · CIK 0001099132

Offering snapshot reported Dec 11, 2014 · SEC filing

Reported sold
$107K
Offering amount: $2.53M
Investors reported
2
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Nov 13, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 11, 2014Initial$106,575No comparison2SEC filing
Feb 23, 2012Amendment$300,000$0vs Feb 23, 20123SEC filing
Feb 23, 2012Initial$300,000No comparison3SEC filing
Jan 17, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$5.33K (estimated)
Finders' fees
$0
Form D file number
021-229935
The Company paid the Placement Agent $5,328 in commissions.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Govdesk, LLC44323

Source: Form D, filed Dec 11, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Leonard Friedman Director, Executive
Frank Georgiou Director
Larry Schatz Director
Chris Theoharis Director, Executive
Emmanuel Tsoupanarias Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
The Chrysler Building 405 Lexington Avenue, 26 Th Floor
New York, NY, 10174